One new home in M/I Homes’ Heritage at Neel Ranch community has an especially meaningful purpose. More than $200,000 from the sale of the Mooresville home will benefit Pelotonia, a
Patients with cancers stemming from non-reproductive organs, such as bladder and liver cancer, have striking discrepancies in incidence, progression, response to treatment and survival outcomes depending on their sex. In almost all cases, male patients have worse prognoses and outcomes.
In 2019, approximately 40% of oncology patients in the United States were eligible for treatment with (ICIs). Furthermore, it is estimated that one in seven patients who receive anti-programmed cell death-1 (PD-1) or PD ligand 1 (PD-L1) antibodies, one in three patients who receive anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibodies, and one in two patients who receive combination PD-(L)1 and CTLA4 antibodies will develop (irAEs).